Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.

about

Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience

P2860

Q58763140-69B7A70D-B3CC-407E-88B0-4BA5471049DF

P2860

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.

Item

http://www.wikidata.org/entity/Q41616541

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of neoadjuvant chemothe ...... advanced-stage ovarian cancer.

@en

type

Item

label

Impact of neoadjuvant chemothe ...... advanced-stage ovarian cancer.

@en

prefLabel

Impact of neoadjuvant chemothe ...... advanced-stage ovarian cancer.

@en

P1476

Impact of neoadjuvant chemothe ...... advanced-stage ovarian cancer

@en

P2093

Inha Lee

http://www.w3.org/2001/XMLSchema#string

Sang Wun Kim

http://www.w3.org/2001/XMLSchema#string

Sunghoon Kim

http://www.w3.org/2001/XMLSchema#string

Young Shin Chung

http://www.w3.org/2001/XMLSchema#string

Young Tae Kim

http://www.w3.org/2001/XMLSchema#string

Yun-Ji Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance chemotherapy for ovarian cancer

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Trends in gynecologic cancer mortality in East Asian regions.

Cancer of the ovary.

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction.

Should studies of maintenance therapy be maintained in women with ovarian cancer?

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.

P304

e0183754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183754

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eun Ji Nam

Jung-Yun Lee

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28873393

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5584794

http://www.w3.org/2001/XMLSchema#string

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.

about

P2860

P2860

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932